PURPOSE: The aim was to compare late-time extrapolation of plasma clearance (CL) from Tikhonov adaptively regularized gamma variate fitting (Tk-GV) and from mono-exponential (E1) fitting. METHODS: Ten (51)Cr-ethylenediaminetetraacetic acid bolus IV studies in adults--8 with ascites--assessed for liver transplantation, with 12-16 plasma samples drawn from 5-min to 24-h, were fit with Tk-GV and E1 models and CL results were compared using Passing-Bablok fitting. RESULTS: The 24-h CL(Tk-GV) values ranged from 11.4 to 79.7 ml/min. Linear regression of 4- versus 24-h CL(Tk-GV) yielded no significant departure from a slope of 1, whereas the 4- versus 24-h CL(E1) slope, 1.56, was significantly increased. For CL(Tk-GV-24-h) versus CL(E1-24-h), there was a biased slope and intercept (0.85, 5.97 ml/min). Moreover, the quality of fitting of 24-h data was significantly better for Tk-GV than for E1, as follows. For 10 logarithm of concentration curves, higher r values were obtained for each Tk-GV fit (median 0.998) than for its corresponding E1 fit (median 0.965), with p < 0.0001 (paired t-test of z-statistics from Fisher r-z transformations). The E1 fit quality degraded with increasing V/W [volume of distribution (l) per kg body weight, p = 0.003]. However, Tk-GV fit quality versus V/W was uncorrelated (p = 0.8). CONCLUSION: CL(E1) values were dependent on sample time and the quality of fit was poor and degraded with increasing ascites, consistent with current opinion that CL(E1) is contraindicated in ascitic patients. CL(Tk-GV) was relatively more accurate and the good quality of fit was unaffected by ascites. CL(Tk-GV) was the preferred method for the accurate calculation of CL and was useful despite liver failure and ascites.
PURPOSE: The aim was to compare late-time extrapolation of plasma clearance (CL) from Tikhonov adaptively regularized gamma variate fitting (Tk-GV) and from mono-exponential (E1) fitting. METHODS: Ten (51)Cr-ethylenediaminetetraacetic acid bolus IV studies in adults--8 with ascites--assessed for liver transplantation, with 12-16 plasma samples drawn from 5-min to 24-h, were fit with Tk-GV and E1 models and CL results were compared using Passing-Bablok fitting. RESULTS: The 24-h CL(Tk-GV) values ranged from 11.4 to 79.7 ml/min. Linear regression of 4- versus 24-h CL(Tk-GV) yielded no significant departure from a slope of 1, whereas the 4- versus 24-h CL(E1) slope, 1.56, was significantly increased. For CL(Tk-GV-24-h) versus CL(E1-24-h), there was a biased slope and intercept (0.85, 5.97 ml/min). Moreover, the quality of fitting of 24-h data was significantly better for Tk-GV than for E1, as follows. For 10 logarithm of concentration curves, higher r values were obtained for each Tk-GV fit (median 0.998) than for its corresponding E1 fit (median 0.965), with p < 0.0001 (paired t-test of z-statistics from Fisher r-z transformations). The E1 fit quality degraded with increasing V/W [volume of distribution (l) per kg body weight, p = 0.003]. However, Tk-GV fit quality versus V/W was uncorrelated (p = 0.8). CONCLUSION:CL(E1) values were dependent on sample time and the quality of fit was poor and degraded with increasing ascites, consistent with current opinion that CL(E1) is contraindicated in asciticpatients. CL(Tk-GV) was relatively more accurate and the good quality of fit was unaffected by ascites. CL(Tk-GV) was the preferred method for the accurate calculation of CL and was useful despite liver failure and ascites.
Authors: John S Fleming; Maureen A Zivanovic; Glen M Blake; Maria Burniston; Philip S Cosgriff Journal: Nucl Med Commun Date: 2004-08 Impact factor: 1.690
Authors: K W Florijn; J N Barendregt; E G Lentjes; W van Dam; W Prodjosudjadi; J L van Saase; L A van Es; P C Chang Journal: Kidney Int Date: 1994-07 Impact factor: 10.612
Authors: Elias Xirouchakis; Laura Marelli; Evangelos Cholongitas; Pinelopi Manousou; Vincenza Calvaruso; Maria Pleguezuelo; Gian Piero Guerrini; Sergio Maimone; Andrew Kerry; Mark Hajjawi; Devaki Nair; Michael Thomas; David Patch; Andrew Kenneth Burroughs Journal: Clin J Am Soc Nephrol Date: 2010-09-09 Impact factor: 8.237
Authors: Surajith N Wanasundara; Michal J Wesolowski; Richard C Puetter; Maria T Burniston; Elias Xirouchakis; Ioannis G Giamalis; Paul S Babyn; Carl A Wesolowski Journal: Nucl Med Commun Date: 2015-04 Impact factor: 1.690
Authors: Surajith N Wanasundara; Michal J Wesolowski; Mark C Barnfield; Michael L Waller; Anthony W Murray; Maria T Burniston; Paul S Babyn; Carl A Wesolowski Journal: Nucl Med Commun Date: 2016-01 Impact factor: 1.690
Authors: Carl A Wesolowski; Surajith N Wanasundara; Paul S Babyn; Jane Alcorn Journal: J Pharmacokinet Pharmacodyn Date: 2019-12-21 Impact factor: 2.745